Bone Biologics Corporation (BBLG) Financials
BBLG Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 4.4 million | 512018 |
| March 31, 2026 | 5.0 million | 309386 |
| Dec. 31, 2025 | 5.8 million | 418587 |
| Sept. 30, 2025 | 6.4 million | 334282 |
BBLG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -518440 | 8253 |
| March 31, 2026 | -804280 | 23505 |
| Dec. 31, 2025 | -714762 | 45674 |
| Sept. 30, 2025 | -591384 | 87180 |
BBLG Net Income
No data available :(
BBLG Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 4.0 million | - | - |
| March 31, 2026 | 4.5 million | - | - |
| Dec. 31, 2025 | 5.3 million | - | - |
| Sept. 30, 2025 | 6.0 million | - | - |
BBLG Shares Outstanding
BBLG Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 308747 | 499359 | - |
| March 31, 2026 | - | 141597 | 663457 | - |
| Dec. 31, 2025 | 5 | 257199 | 475908 | - |
| Sept. 30, 2025 | - | 187808 | 527466 | - |
BBLG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
BBLG
Price: $0.64
52 week price:
Earnings Per Share: -1.16 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 118500
Market Capitalization: 1.2 million